Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.

• Päätekijät: Cynthia Sung (Tekijä), Yuan Wei (Tekijä), Satoru Watanabe (Tekijä), How Sung Lee (Tekijä), Yok Moi Khoo (Tekijä), Lu Fan (Tekijä), Abhay P S Rathore (Tekijä), Kitti Wing-Ki Chan (Tekijä), Milly M Choy (Tekijä), Uma S Kamaraj (Tekijä), October M Sessions (Tekijä), Pauline Aw (Tekijä), Paola F de Sessions (Tekijä), Bernett Lee (Tekijä), John E Connolly (Tekijä), Martin L Hibberd (Tekijä), Dhanasekaran Vijaykrishna (Tekijä), Limin Wijaya (Tekijä), Eng Eong Ooi (Tekijä), Jenny Guek-Hong Low (Tekijä), Subhash G Vasudevan (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Public Library of Science (PLoS), 2016-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

UNLABELLED:CELADEN was a randomized placebo-controlled trial of 50 patients with confirmed dengue fever to evaluate the efficacy and safety of celgosivir (A study registered at ClinicalTrials.gov, number NCT01619969). Celgosivir was given as a 400 mg loading dose and 200 mg bid (twice a day) over 5...